cGMP Method Development & Validation
Develop, optimize, verify, and validate analytical procedures for regulated pharmaceutical materials, complex matrices, and solid-state questions.
Method development, validation, verification, transfer, and release-support services.
This section summarizes Triclinic’s method-development, validation, and transfer pages for cGMP method development and validation, cGMP release testing, and cGMP method transfer. The focus is not generic checklist validation; it is aligning the method, material, matrix, acceptance criteria, quality status, and intended decision.
Method lifecycle service areas
Use these pages when a method must be built, optimized, verified, validated, transferred, or executed in a way that supports release, stability, investigation, CMC, regulatory, or quality decisions.
cGMP Release Testing
Execute controlled release or specification testing under the appropriate method status, documentation, review, and quality expectations.
cGMP Method Transfer
Transfer analytical methods between laboratories, instruments, analysts, sites, or quality systems while preserving intended use and acceptance criteria.
How to use this section
Start by deciding whether the problem is development, validation, verification, transfer, or routine execution. A development method, a compendial method, a release test, and a transferred method require different evidence packages.
Common Questions
What is the difference between development, validation, verification, transfer, and execution?
Development builds or optimizes a method. Validation demonstrates that a noncompendial method is fit for its intended use. Verification confirms suitable performance of an established or compendial method. Transfer demonstrates that another laboratory or setting can execute the method. Execution is routine testing after the method status is appropriate.
Can an R&D method be used for release testing?
Not automatically. Release testing generally requires defined method status, specifications, system suitability, validation or verification evidence, controlled documentation, and a reporting path appropriate for the quality system.
Which techniques may be involved?
Methods may involve XRPD, Raman, FTIR, NMR, microscopy, HPLC/UPLC, GC, LC/MS, DSC, TGA, DVS, Karl Fischer, particle size, optical methods, elemental analysis, or orthogonal combinations.
What information should be provided before method work starts?
Provide the method or draft procedure, intended use, material identity, sample matrix, acceptance criteria, prior data, reference standards, known interferences, sample handling requirements, and quality status.
Can Triclinic support cGMP analytical methods?
Yes. Triclinic can support cGMP method development, validation, verification, transfer, execution, and release testing when the technique, sample matrix, specifications, documentation, and quality-system requirements fit the agreed scope.
Discuss the method decision before writing the protocol
Tell Triclinic what material, method, matrix, acceptance criteria, regulatory status, and timeline are driving the work.
